PubRank

Peter K Henke

Author PubWeight™ 119.31‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation 2005 2.67
2 Regional intensity of vascular care and lower extremity amputation rates. J Vasc Surg 2013 1.95
3 Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol 2008 1.93
4 Differential regulation of aortic growth in male and female rodents is associated with AAA development. J Surg Res 2008 1.72
5 Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J 2008 1.71
6 Surgical treatment of intact thoracoabdominal aortic aneurysms in the United States: hospital and surgeon volume-related outcomes. J Vasc Surg 2003 1.63
7 A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg 2010 1.59
8 Identifying patients at high risk for venous thromboembolism requiring treatment after outpatient surgery. Ann Surg 2012 1.55
9 Gender differences in experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol 2004 1.51
10 Proteomics of microparticles after deep venous thrombosis. Thromb Res 2010 1.50
11 The Michigan Surgical Quality Collaborative: a legacy of Shukri Khuri. Am J Surg 2009 1.48
12 Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg 2007 1.47
13 Pediatric renovascular hypertension: 132 primary and 30 secondary operations in 97 children. J Vasc Surg 2006 1.47
14 Critical review of mouse models of venous thrombosis. Arterioscler Thromb Vasc Biol 2012 1.46
15 L-selectin-mediated neutrophil recruitment in experimental rodent aneurysm formation. Circulation 2005 1.44
16 Attending, house officer, and medical student perceptions about teaching in the third-year medical school general surgery clerkship. J Am Coll Surg 2004 1.39
17 Impaired vasoreactivity despite an increase in plasma nitrite in patients with abdominal aortic aneurysms. J Vasc Surg 2002 1.39
18 Variation in death rate after abdominal aortic aneurysmectomy in the United States: impact of hospital volume, gender, and age. Ann Surg 2002 1.37
19 A true aneurysm of the profunda femoris artery: a case report and review of the English language literature. Ann Vasc Surg 2004 1.34
20 Decreased venous thrombosis with an oral inhibitor of P selectin. J Vasc Surg 2005 1.34
21 Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model. J Vasc Surg 2005 1.30
22 A negative carotid plaque area test is superior to other noninvasive atherosclerosis studies for reducing the likelihood of having underlying significant coronary artery disease. Arterioscler Thromb Vasc Biol 2005 1.29
23 Surgeon specialty and provider volumes are related to outcome of intact abdominal aortic aneurysm repair in the United States. J Vasc Surg 2003 1.27
24 Racial disparities in the use of revascularization before leg amputation in Medicare patients. J Vasc Surg 2011 1.22
25 Female gender attenuates cytokine and chemokine expression and leukocyte recruitment in experimental rodent abdominal aortic aneurysms. Ann N Y Acad Sci 2006 1.22
26 Variation in the use of lower extremity vascular procedures for critical limb ischemia. Circ Cardiovasc Qual Outcomes 2011 1.20
27 Payer status is related to differences in access and outcomes of abdominal aortic aneurysm repair in the United States. Surgery 2003 1.17
28 D-dimer, P-selectin, and microparticles: novel markers to predict deep venous thrombosis. A pilot study. Thromb Haemost 2005 1.17
29 Neutropenia impairs venous thrombosis resolution in the rat. J Vasc Surg 2003 1.12
30 A national and single institutional experience in the contemporary treatment of acute lower extremity ischemia. Ann Surg 2003 1.10
31 Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis. Clin Appl Thromb Hemost 2011 1.09
32 Venous thromboembolism in cancer patients undergoing major surgery. Ann Surg Oncol 2008 1.07
33 Acute venous disease: venous thrombosis and venous trauma. J Vasc Surg 2007 1.06
34 Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis. J Vasc Surg 2006 1.05
35 Common celiacomesenteric trunk: aneurysmal and occlusive disease. J Vasc Surg 2004 1.05
36 Resolution of venous thrombosis using a novel oral small-molecule inhibitor of P-selectin (PSI-697) without anticoagulation. Thromb Haemost 2007 1.04
37 Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis. Thromb Haemost 2009 1.02
38 Surgical mentors' and mentees' productivity from 1993 to 2006. Am J Surg 2010 1.02
39 Diffusion of new technology in health care: the case of aorto-iliac occlusive disease. Surgery 2004 1.00
40 A nonintrinsic regional basis for increased infrarenal aortic MMP-9 expression and activity. J Vasc Surg 2003 1.00
41 Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism. Thromb Haemost 2010 0.99
42 A validated risk model to predict 90-day VTE events in postsurgical patients. Chest 2014 0.99
43 Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular Surgery ® and the American Venous Forum. J Vasc Surg 2014 0.98
44 Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis. J Vasc Surg 2011 0.97
45 Early MT-1 MMP expression following elastase exposure is associated with increased cleaved MMP-2 activity in experimental rodent aortic aneurysms. Surgery 2004 0.97
46 Decreased collagen and increased matrix metalloproteinase-13 in experimental abdominal aortic aneurysms in males compared with females. Surgery 2009 0.97
47 Aging is associated with impaired thrombus resolution in a mouse model of stasis induced thrombosis. Thromb Res 2009 0.96
48 Southern Association for Vascular Surgery William J. von Leibig Award. Inflammation and intimal hyperplasia associated with experimental pulmonary embolism. J Vasc Surg 2002 0.96
49 Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution. J Surg Res 2007 0.95
50 Tamoxifen up-regulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic aneurysms. J Vasc Surg 2005 0.95
51 P-selectin/ PSGL-1 inhibitors versus enoxaparin in the resolution of venous thrombosis: a meta-analysis. Thromb Res 2009 0.94
52 The role of inflammation in early and late venous thrombosis: Are there clinical implications? Semin Vasc Surg 2005 0.94
53 Postthrombotic vein wall remodeling: preliminary observations. J Vasc Surg 2010 0.94
54 A contemporary comparison of aortofemoral bypass and aortoiliac stenting in the treatment of aortoiliac occlusive disease. Ann Vasc Surg 2010 0.94
55 Gender-dependent differential phosphorylation in the ERK signaling pathway is associated with increased MMP2 activity in rat aortic smooth muscle cells. J Surg Res 2009 0.94
56 P-selectin inhibition enhances thrombus resolution and decreases vein wall fibrosis in a rat model. J Vasc Surg 2002 0.93
57 Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin. J Vasc Surg 2008 0.93
58 The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic vein wall remodeling. J Vasc Surg 2013 0.92
59 The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis. J Vasc Surg 2012 0.92
60 Vein wall remodeling after deep vein thrombosis: differential effects of low molecular weight heparin and doxycycline. Ann Vasc Surg 2010 0.91
61 Ultrasound measurement of aortic diameters in rodent models of aneurysm disease. J Surg Res 2003 0.91
62 Gender differences in rat aortic smooth muscle cell matrix metalloproteinase-9. J Am Coll Surg 2005 0.91
63 A biologic basis for asymmetric growth in descending thoracic aortic aneurysms: a role for matrix metalloproteinase 9 and 2. J Vasc Surg 2006 0.91
64 Factors associated with outcome after interventional treatment of symptomatic iliac vein compression syndrome. J Vasc Surg 2007 0.90
65 Effect of increasing patient age on complication rates following intact abdominal aortic aneurysm repair in the United States. J Surg Res 2004 0.89
66 Iliorenal bypass: indications and outcomes following 41 reconstructions. Ann Vasc Surg 2007 0.89
67 The role of extracellular signal-related kinase during abdominal aortic aneurysm formation. J Am Coll Surg 2012 0.88
68 Inflammation modulates murine venous thrombosis resolution in vivo: assessment by multimodal fluorescence molecular imaging. Arterioscler Thromb Vasc Biol 2012 0.88
69 Increased MMP-9 expression and activity by aortic smooth muscle cells after nitric oxide synthase inhibition is associated with increased nuclear factor-kappaB and activator protein-1 activity. J Surg Res 2004 0.88
70 Differential effect of 17-beta-estradiol on smooth muscle cell and aortic explant MMP2. J Surg Res 2008 0.87
71 Epidemiology of aortic aneurysm repair in the United States from 1993 to 2003. Ann N Y Acad Sci 2006 0.87
72 Carotid endarterectomy remains the standard of care, even in high-risk surgical patients. Ann Surg 2005 0.87
73 Risk factors associated with venous thromboembolic events in patients with malignancy. Blood Coagul Fibrinolysis 2006 0.87
74 The effect of increased hip flexion using stirrups on lower-extremity venous flow: a prospective observational study. Am J Surg 2011 0.87
75 Venous thromboembolism: regional differences in the nationwide inpatient sample, 1993 to 2000. Vascular 2005 0.86
76 Predictors of severe morbidity and death after elective abdominal aortic aneurysmectomy in patients with chronic obstructive pulmonary disease. J Vasc Surg 2003 0.86
77 Deep vein thrombosis resolution is not accelerated with increased neovascularization. J Vasc Surg 2004 0.86
78 Microparticle surface protein are associated with experimental venous thrombosis: a preliminary study. Clin Appl Thromb Hemost 2009 0.86
79 Diffusion of new technology for the treatment of renovascular hypertension in the United States: surgical revascularization versus catheter-based therapy, 1988-2001. J Vasc Surg 2004 0.85
80 High-resolution ultrasound speckle tracking may detect vascular mechanical wall changes in peripheral artery bypass vein grafts. Ann Vasc Surg 2008 0.85
81 P-selectin inhibition decreases post-thrombotic vein wall fibrosis in a rat model. Surgery 2003 0.85
82 Increased PAI-1 in females compared with males is protective for abdominal aortic aneurysm formation in a rodent model. Am J Physiol Heart Circ Physiol 2012 0.85
83 Increased 18F-FDG uptake is predictive of rupture in a novel rat abdominal aortic aneurysm rupture model. Ann Surg 2015 0.84
84 Ruptured thoracoabdominal aortic aneurysm treatment in the United States: 1988 to 1998. J Vasc Surg 2003 0.84
85 The electrolytic inferior vena cava model (EIM) to study thrombogenesis and thrombus resolution with continuous blood flow in the mouse. Thromb Haemost 2013 0.83
86 Factors associated with recurrent venous thromboembolism in patients with malignant disease. J Vasc Surg 2003 0.83
87 Increased JNK in males compared with females in a rodent model of abdominal aortic aneurysm. J Surg Res 2011 0.83
88 Experimental pulmonary embolism: effects of the thrombus and attenuation of pulmonary artery injury by low-molecular-weight heparin. J Vasc Surg 2006 0.82
89 Implementation of a small bowel obstruction guideline improves hospital efficiency. Surgery 2012 0.82
90 Individualized Venous Thromboembolism Risk Stratification Using the 2005 Caprini Score to Identify the Benefits and Harms of Chemoprophylaxis in Surgical Patients: A Meta-analysis. Ann Surg 2017 0.81
91 Prophylactic Inferior Vena Cava Filter Placement Does Not Result in a Survival Benefit for Trauma Patients. Ann Surg 2015 0.81
92 The effect of secondary operations on mortality following abdominal aortic aneurysm repair in the United States: 1988-2001. Vasc Endovascular Surg 2005 0.81
93 Outcome of surgical and endoluminal intervention for infrainguinal bypass anastomotic strictures. Vasc Endovascular Surg 2006 0.81
94 Hospital volume-related differences in aorto-bifemoral bypass operative mortality in the United States. J Vasc Surg 2003 0.81
95 The vessel wall: A forgotten player in post thrombotic syndrome. Thromb Haemost 2010 0.81
96 Deletion of cysteine-cysteine receptor 7 promotes fibrotic injury in experimental post-thrombotic vein wall remodeling. Arterioscler Thromb Vasc Biol 2013 0.81
97 Soluble P-selectin for the diagnosis of lower extremity deep venous thrombosis. J Vasc Surg Venous Lymphat Disord 2013 0.80
98 Role of selectins and fibrinolysis in VTE. Thromb Res 2009 0.80
99 Matrix metalloproteinase-9 deletion is associated with decreased mid-term vein wall fibrosis in experimental stasis DVT. Thromb Res 2013 0.80
100 Differential gender- and species-specific formation of aneurysms using a novel method of inducing abdominal aortic aneurysms. J Surg Res 2012 0.80
101 Epidemiology of surgically treated abdominal aortic aneurysms in the United States, 1988 to 2000. Vascular 2005 0.79
102 Endovascular treatment of abdominal aortic aneurysm is associated with a low incidence of deep venous thrombosis. J Vasc Surg 2002 0.79
103 Attenuation of experimental aortic aneurysm formation in P-selectin knockout mice. Ann N Y Acad Sci 2006 0.79
104 Differential regulation of the superoxide dismutase family in experimental aortic aneurysms and rat aortic explants. J Surg Res 2006 0.79
105 Venous thromboembolism: a collaborative quality improvement model for practitioners, hospitals, and insurers. J Thromb Thrombolysis 2012 0.79
106 Gadolinium as a nonnephrotoxic contrast agent for catheter-based arteriographic evaluation of renal arteries in patients with azotemia. J Vasc Surg 2003 0.78
107 Variation in physician deep vein thrombosis prophylaxis attitudes and practices at an academic tertiary care center. J Thromb Thrombolysis 2010 0.78
108 Cellular IL-10 is more effective than viral IL-10 in decreasing venous thrombosis. J Surg Res 2003 0.78
109 Uncomplicated carotid endarterectomy: factors contributing to blood pressure instability precluding safe early discharge. Vascular 2005 0.77
110 Risk for stroke after elective noncarotid vascular surgery. J Vasc Surg 2004 0.77
111 Update in venous thromboembolism pathophysiology, diagnosis, and treatment for surgical patients. Curr Probl Surg 2015 0.77
112 Mitochondrial-dependent apoptosis in experimental rodent abdominal aortic aneurysms. Surgery 2005 0.77
113 Diagnosis, prevention, and treatment of claudication. Surg Clin North Am 2013 0.77
114 The nitric oxide donor DETA-NONOate decreases matrix metalloproteinase-9 expression and activity in rat aortic smooth muscle and abdominal aortic explants. Ann Vasc Surg 2006 0.77
115 Inflammation and thrombosis: new insights. Front Biosci (Schol Ed) 2012 0.77
116 Existence of abdominal aortic aneurysms in patients with thoracic aortic dissections. J Vasc Surg 2003 0.77
117 Reliability of the clinical examination in the diagnosis of neurogenic versus vascular claudication. Spine J 2013 0.76
118 Impact of adding aspirin to beta-blocker and statin in high-risk patients undergoing major vascular surgery. Ann Vasc Surg 2013 0.76
119 Outcomes after late explantation of aortic endografts depend on indication for explantation. Ann Vasc Surg 2013 0.75
120 Utility of (18) F-FDG and (11)C-PBR28 microPET for the assessment of rat aortic aneurysm inflammation. EJNMMI Res 2014 0.75
121 Cost of routine screening for carotid and lower extremity occlusive disease in patients with abdominal aortic aneurysms. J Vasc Surg 2002 0.75
122 Invited commentary. J Vasc Surg 2010 0.75
123 Outcomes of endovascular interventions for salvage of renal transplant allografts. J Vasc Surg 2013 0.75
124 Intravascular ultrasound-guided true lumen reentry device for recanalization of unilateral chronic total occlusion of iliac arteries: technique and follow-up. Ann Vasc Surg 2010 0.75
125 Marjolin's ulcer in a patient with chronic venous stasis. Ann Vasc Surg 2013 0.75
126 Severe chronic venous insufficiency: magnitude of the problem and consequences. Ann Vasc Surg 2005 0.75
127 Chronic venous insufficiency: current management of varicose vein disease. Am Surg 2010 0.75
128 E-selectin inhibition with GMI-1271 decreases venous thrombosis without profoundly affecting tail vein bleeding in a mouse model. Thromb Haemost 2017 0.75
129 Pediatric splanchnic arterial occlusive disease: clinical relevance and operative treatment. J Vasc Surg 2002 0.75
130 Gram-Negative Pneumonia Alters Large-Vein Cell-Adhesion Molecule Profile and Potentiates Experimental Stasis Venous Thrombosis. J Vasc Res 2016 0.75
131 The Sixth Pacific Vascular Symposium: the venous ulcer summit. Arterioscler Thromb Vasc Biol 2010 0.75
132 Diffusion of Alexa Fluor 488-conjugated dendrimers in rat aortic tissue. Ann N Y Acad Sci 2006 0.75
133 Collaboration based on the clinical model can help grow the physician-scientist. Am J Surg 2003 0.75
134 All deep vein thrombosis patients should be routinely screened for thrombophilia. Dis Mon 2010 0.75
135 Operative mortality rate for elective abdominal aortic aneurysm repair is not increased by the presence of a previous or concurrent thoracic or thoracoabdominal aortic dissection. J Vasc Surg 2002 0.75
136 Longevity and outcomes of axillary valve transplantation for severe lower extremity chronic venous insufficiency. Ann Vasc Surg 2011 0.75